XML 87 R70.htm IDEA: XBRL DOCUMENT v3.24.1
Stockholders’ Equity (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Mar. 13, 2024
Jan. 26, 2024
Oct. 17, 2023
Mar. 07, 2023
Jun. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Feb. 15, 2024
Nov. 30, 2022
Mar. 28, 2022
Dec. 31, 2021
Class of Stock [Line Items]                      
Preferred stock, per share           $ 0.001 $ 0.001        
Preferred stock, stated value           $ 18,625,000        
Common stock, shares authorized         200,000,000 200,000,000 200,000,000        
Increase in common stock authorized         100,000,000            
Common stock, shares issued           42,329,864 40,518,792        
Common stock, shares outstanding           42,329,864 40,518,792        
Proceeds from issuance of common stock           $ 1,807,000        
Commited Equity Facility [Member] | Cantor Fitzgerald [Member]                      
Class of Stock [Line Items]                      
Issuance of common stock           680,263          
Common stock authorized for sale                   $ 50,000,000  
Proceeds from issuance of common stock           $ 1,800,000          
Percentage of discount on sale of stock           4.00%          
Controlled Equity Offering Agreement [Member] | Cantor Fitzgerald [Member]                      
Class of Stock [Line Items]                      
Common stock authorized for sale                 $ 6,500,000    
Number of shares issued in ATM offering           230,068          
Proceeds from issuance of shares in ATM offering           $ 300,000          
Percentage of commission paid to broker           3.00%          
Pavmed Inc [Member]                      
Class of Stock [Line Items]                      
Majority-interest equity ownership shares           31,302,420          
Common Stock [Member]                      
Class of Stock [Line Items]                      
Majority-interest equity ownership shares           42,329,864 40,518,792       34,917,907
Number of shares issued in ATM offering           230,068          
Subsequent Event [Member] | Pavmed Inc [Member]                      
Class of Stock [Line Items]                      
Issuance of common stock   3,331,771                  
Subsequent Event [Member] | Management Services Agreement [Member]                      
Class of Stock [Line Items]                      
Monthly payment owed for MSA fees   $ 4,675,000                  
Subsequent Event [Member] | Pavmed Inc [Member]                      
Class of Stock [Line Items]                      
Majority-interest equity ownership shares               31,302,444      
Subsequent Event [Member] | Common Stock [Member] | Minimum [Member]                      
Class of Stock [Line Items]                      
Average price per share $ 8.00                    
Series A Preferred Stock [Member]                      
Class of Stock [Line Items]                      
Preferred stock, shares issued       13,625              
Preferred stock, per share       $ 0.001              
Average price per share       $ 1,000              
Proceeds from sale of shares       $ 13,625,000              
Preferred stock, stated value       $ 1,000              
Preferred stock, conversion price per share       $ 1.394              
Preferred stock dividend payment terms       The holders of Series A Preferred Stock will be entitled to dividends payable as follows: (i) a number of shares of Common Stock equal to 20% of the number of shares of Common Stock issuable upon conversion of the Series A Preferred Stock then held by such Holder on March 7, 2024, and (ii) a number of shares of Common Stock equal to 20% of the number of shares of Common Stock issuable upon conversion of the Series A Preferred Stock then held by such Holder on March 7, 2025. A holder that converts its Series A Preferred Stock prior to March 7, 2024 or March 7, 2025, as the case may be, will not receive the dividend that accrues on such date with respect to such converted Series A Preferred Stock. The holders of the Series A Preferred Stock also will be entitled to dividends equal, on an as-if-converted to shares of Common Stock basis, to and in the same form as dividends actually paid on shares of the Common Stock when, as, and if such dividends are paid on shares of the Common Stock.              
Conversion of stock, description       The Company will not effect any conversion of the Series A Preferred Stock, and a holder will not have the right to receive dividends or convert any portion of the Series A Preferred Stock, to the extent that, after giving effect to the receipt of dividends or the conversion, the holder (together with such holder’s affiliates, and any persons acting as a group together with such holder or any of the holder’s affiliates) would beneficially own in excess of 4.99% of the Company’s outstanding common stock (or, upon election of the holder, 9.99% of the Company’s outstanding common stock).              
Series A Preferred Stock [Member] | Subsequent Event [Member]                      
Class of Stock [Line Items]                      
Preferred stock, shares outstanding 0                    
Series A-1 Preferred Stock [Member]                      
Class of Stock [Line Items]                      
Preferred stock, shares issued     5,000     18,625 0        
Proceeds from sale of shares     $ 5,000,000.0                
Preferred stock, conversion price per share     $ 1.2592                
Preferred stock, shares outstanding           18,625 0        
Series A-1 Preferred Stock [Member] | Subsequent Event [Member]                      
Class of Stock [Line Items]                      
Preferred stock, shares outstanding 0                    
Series B Preferred Stock [Member] | Subsequent Event [Member]                      
Class of Stock [Line Items]                      
Preferred stock, shares issued 5,670                    
Series B Convertible Preferred Stock [Member] | Subsequent Event [Member]                      
Class of Stock [Line Items]                      
Preferred stock, shares issued 44,285                    
Proceeds from sale of shares $ 18,100,000                    
Preferred stock, conversion price per share $ 1.2444